跳至主要内容
临床试验/JPRN-jRCT1030210283
JPRN-jRCT1030210283招募中未知

Effect of nitric oxide synthase (NOS) activity on Lenvatinib for unresectable hepatocellular carcinoma

Hidaka Hisashi0 个研究点目标入组 100 人开始时间: 2021年8月27日最近更新:

试验速览

阶段
未知
状态
招募中
发起方
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
>= 20age old 至 ot applicable(—)
性别
All

入选标准

  • Patients with hepatocellular carcinoma who received lenvatinib between October 1, 2018 and September 30, 2020.
  • Patients enrolled in the Multicenter Study of Factors Contributing to the Efficacy and Survival of Lenvatinib in Hepatocellular Carcinoma.
  • Patients who have arbitrarily stored serum before and after treatment.

排除标准

  • Patients who are considered unsuitable for participation in this study by the principal investigator and sub-investigators

研究者

发起方
Hidaka Hisashi

相似试验